Compounds > satavaptan
Page last updated: 2024-09-04

satavaptan and Kidney, Polycystic

satavaptan has been researched along with Kidney, Polycystic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchholz, B; Donauer, J; Dworniczak, B; Eckardt, KU; Gerke, P; Geyer, M; Gloy, J; Kumar, R; Neumann, HP; Pennekamp, P; Puetz, M; Romaker, D; Rumberger, B; Teschner, S; Walz, G1
Buechert, M; Hadjidemetriou, S; Hennig, J; Reichardt, W; von Elverfeldt, D1

Other Studies

2 other study(ies) available for satavaptan and Kidney, Polycystic

ArticleYear
Increased expression of secreted frizzled-related protein 4 in polycystic kidneys.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:1

    Topics: Animals; Cells, Cultured; Cyst Fluid; Disease Models, Animal; Humans; Kidney; Mice; Morpholines; Nephrons; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Proto-Oncogene Proteins; Signal Transduction; Spiro Compounds; Transcription Factors; TRPP Cation Channels; Wnt Proteins; Xenopus; Zebrafish

2009
Analysis of MR images of mice in preclinical treatment monitoring of polycystic kidney disease.
    Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2009, Volume: 12, Issue:Pt 2

    Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Mice; Morpholines; Polycystic Kidney Diseases; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Spiro Compounds; Treatment Outcome

2009